Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Research
Using tumor ‘avatar’ to predict patients’ immunotherapy response
Researchers have explored a revolutionary way to predict a patient's response to immunotherapies by creating a tumor “avatar” from biopsies.
Marissa Russo
Oct 21, 2026 11:50am
CBER Director Mikhail feels FDA is ‘getting back to stability’
Oct 21, 2026 8:00am
Merck KGaA spinout iOnctura touts PI3K inhibitor in eye cancer
Oct 14, 2026 1:42pm
Vir CEO sees chance ‘to do more deals’ after $1.9B Gilead pact
Oct 14, 2026 8:30am
How Nobel-winning optogenetics is being harnessed by biotechs
Oct 9, 2026 9:30am
‘It’s just survival’: Why a third of Boston lab space sits empty
Oct 8, 2026 8:00am
